Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

ARS Pharma CLO Slebir Receives 1,199,482 Stock Options

ARS Pharmaceuticals, Inc. Chief Legal Officer John L. Slebir filed a statement of changes in beneficial ownership on November 4, 2026, disclosing the acquisition of stock options on November 2, 2026.

Anjali Anand | 04 November 2026

Helen Jane Sheirbon Joins Avery Dennison as President, Solutions Group

An initial statement of beneficial ownership was filed on November 4, 2026, disclosing that Helen Jane Sheirbon became an officer of Avery Dennison Corp, listed on the New York Stock Exchange as NYSE:AVY, following a triggering event dated November 3, 2026.

Vinay Lochav | 04 November 2026

Da-Wai Hu Files Initial Ownership Form as Live Nation EVP

Da-Wai Hu, Executive Vice President and General Counsel of Live Nation Entertainment, Inc., filed a Form 3 initial statement of beneficial ownership with the SEC on November 4, 2026, reflecting a triggering event date of November 2, 2026.

Nitish Kishor | 04 November 2026

ARS Pharmaceuticals CLO Slebir Files Initial Ownership Statement

John L. Slebir, Chief Legal Officer of ARS Pharmaceuticals, Inc., filed a Form 3 initial statement of beneficial ownership with the SEC on November 4, 2026, disclosing no securities beneficially owned as of the event date of October 26, 2026.

Vinay Lochav | 04 November 2026

Robert Wong Gets 25,000 Stock Options at $11.30 from Retension Pharma

Robert Wong, VP and Chief Accounting Officer of Retension Pharmaceuticals, Inc., reported the grant of 25,000 stock options on November 2, 2026, in a statement of changes in beneficial ownership filed with the SEC on November 4, 2026.

Nitish Kishor | 04 November 2026

Garechana Receives 1,938 RSUs from InvenTrust Properties

Director Robert Garechana filed a Form 4 with the SEC on November 4, 2026, disclosing the acquisition of 1,938 restricted stock units in InvenTrust Properties Corp. (NYSE:IVT).

Nitish Kishor | 04 November 2026

InvenTrust Appoints Garechana to Board, Audit Committee

InvenTrust Properties Corp. filed a Form 8-K on November 4, 2026, disclosing the appointment of Robert A. Garechana to its Board of Directors and Audit Committee, effective immediately.

Nitish Kishor | 04 November 2026

Ternullo Reports 41,108 Shares After SVRN Reverse Split

Salvatore J. Ternullo, Chief Executive Officer and Director of SVRN, Inc., filed an amended initial statement of beneficial ownership on November 4, 2026, correcting how a restricted stock award was previously categorized and reflecting share counts adjusted for a 1-for-20 reverse stock split.

Anjali Anand | 04 November 2026

Robert Garechana Files Form 3 as New InvenTrust Director

Robert Garechana submitted an initial statement of beneficial ownership as a newly appointed director of InvenTrust Properties Corp., filed on November 4, 2026, disclosing no securities beneficially owned.

Aditi Sarkar | 04 November 2026

Robert Wong Files Initial Ownership Form, Reports No Securities

Robert Wong, VP and Chief Accounting Officer of Retension Pharmaceuticals, Inc., filed an initial statement of beneficial ownership with the SEC on November 4, 2026, disclosing no securities held as of his event date of November 2, 2026.

Manish Choudhary | 04 November 2026
Support

Hi! How can we help you today?

Loading…